Zenas BioPharma, Inc. Revenue 2023–2025
Zenas BioPharma, Inc. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zenas BioPharma, Inc. revenue for the quarter ending September 30, 2025 was 0.
- Zenas BioPharma, Inc. revenue for the twelve months ending September 30, 2025 was 10.0 M.
- Zenas BioPharma, Inc. annual revenue for 2025 was 10.0 M, a 100.00% increase from 2024.
- Zenas BioPharma, Inc. annual revenue for 2024 was 5.0 M, a 90.00% decrease from 2023.
- Zenas BioPharma, Inc. annual revenue for 2023 was 50.0 M.
Zenas BioPharma, Inc. (ZBIO) — Frequently Asked Questions
Zenas BioPharma, Inc. (ZBIO) is a publicly traded US company. It has a market capitalization of $801M. In fiscal 2025 it reported revenue of $10M and net income of -$378M. Explore ZBIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Zenas BioPharma, Inc.'s market cap?
Zenas BioPharma, Inc. (ZBIO) has a market capitalization of $801M.
What is the ZBIO stock price?
ZBIO trades at $17.91 (-2.77% on the day).
How much revenue does Zenas BioPharma, Inc. make?
Zenas BioPharma, Inc. reported revenue of $10M in fiscal 2025.
Is ZBIO profitable?
In fiscal 2025, Zenas BioPharma, Inc. reported net income of -$378M.